Physician

Edit Tolnai, M.D.

According to 2025 Medicare claims, Edit Tolnai, M.D. (NPI: 1558358630) practices hematology in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is LEE HEALTH SYSTEM INC (NPI: 1942058557; TIN: 992646504) and primary practice location at 33905-7813. Tolnai is affiliated with the Physician Quality Partners, LLC (ACO ID: A2778) and Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Tolnai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 394 traditional Medicare patients, billed 49,036 HCPCS/CPT codes, and received $800,412 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 298 prescription claims across 95 beneficiaries totaling $452,167 in drug costs, led by Calquence (Acalabrutinib Maleate). 2016 DME data shows 27 claims. Open Payments data shows 4 records totaling $168. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $896,843 to $452,167. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	398	98,736	$918,505
2016	414	109,784	$1,337,975
2017	383	103,839	$1,218,838
2018	366	164,755	$1,043,950
2019	397	172,931	$1,900,667
2020	412	161,080	$1,718,956
2021	418	119,348	$2,158,811
2022	409	113,669	$2,451,708
2023	427	98,519	$1,689,263
2024	394	49,036	$800,412

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	1,146	$896,843
2016	157	1,245	$1,355,222
2017	168	1,297	$1,566,080
2018	157	1,243	$1,671,239
2019	177	1,336	$2,071,737
2020	200	1,443	$2,834,856
2021	194	1,513	$4,293,588
2022	194	1,334	$3,546,448
2023	187	1,107	$2,698,433
2024	95	298	$452,167

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$4,508
2016	N/R	27	$3,749
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	73	104	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	83	180	$95
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	56	66	$43
J0897	Injection, denosumab, 1 mg	43	3,360	$20
96372	Injection of drug or substance under skin or into muscle	94	125	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	12	360	$139,960
Eliquis	Apixaban	31	1,380	$25,423
Anastrozole	Anastrozole	30	1,290	$392
Pantoprazole Sodium	Pantoprazole Sodium	43	2,010	$379
Tamoxifen Citrate	Tamoxifen Citrate	15	870	$362

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$168	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edit Tolnai, M.D.?

Tedicare shows public-source Medicare data for Edit Tolnai, M.D. (NPI 1558358630), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edit Tolnai, M.D. have ACO affiliation data?

Edit Tolnai, M.D. is shown with ACO affiliation data for Physician Quality Partners, LLC (MSSP, ACO ID A2778) and Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Edit Tolnai, M.D.?

Edit Tolnai, M.D. is linked to LEE HEALTH SYSTEM INC (billing NPI 1942058557) in the available physician profile data.

Does Edit Tolnai, M.D. have Open Payments data?

Edit Tolnai, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.